BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert and its engineering subsidiary CEO Randall Moore tell Proactive it has recently been notified of several new contract awards worth more than $1.2 million in revenue, most of which will be earned over the next six months. The recent wins are expected to increase its operating cash flow, which will support its plans for top-line revenue growth and its efforts to commercialize several of its patented environmental technologies
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
No comments:
Post a Comment